Competing Risk Analysis in Lung Cancer Patients Over 80 Years Old Undergoing Surgery. 2019

Haruaki Hino, and Takahiro Karasaki, and Yukihiro Yoshida, and Takeshi Fukami, and Atsushi Sano, and Makoto Tanaka, and Yoshiaki Furuhata, and Kosuke Kashiwabara, and Junji Ichinose, and Mitsuaki Kawashima, and Jun Nakajima
Department of Thoracic Surgery, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, 35-2 Sakaecho Itabashi-ku, Tokyo, 173-0015, Japan.

This study aimed to analyze cause-specific mortality in lung cancer patients over 80 years old undergoing surgery. This retrospective, multi-institutional analysis included patients aged ≥ 80 years who underwent radical surgery for primary lung cancer from January 1998 to December 2015. Preoperative clinical data, surgical results, survival, and cause of death were evaluated. Competing risk analysis for cause-specific mortality was performed. Of the 337 patients (median age 82 years) enrolled and analyzed, 68.1% were male. There were 52 and 44 cancer-specific and non-cancer-specific deaths, respectively. On competing risk regression analysis, non-cancer-specific deaths were significantly associated with male sex (hazard ratio [HR]: 3.06, 95% confidence interval [CI]: 1.02-9.12, p = 0.046), coronary artery disease (HR: 2.49, 95% CI: 2.49 [1.14-5.47], p = 0.02), interstitial pneumonia (HR: 3.58, 95% CI: 1.73-7.40, p < 0.001), and pathological stage III (HR: 3.83, 95% CI: 1.44-10.13, p = 0.007). In contrast, cancer-specific deaths were significantly associated with limited resection (HR: 1.99, 95% CI: 1.02-3.89, p = 0.04) and pathological stage III (HR: 3.13, 95% CI: 1.44-6.80, p = 0.004). The 5-year cumulative incidences of lung cancer-specific and non-cancer-specific deaths were 18.0% and 15.9%, respectively. Prognostic factors for non-cancer-specific death were different from those of cancer-specific death, except for pathological stage. Each prognostic factor should be considered when deciding surgical indication and procedure and monitoring for pulmonary events during outpatient follow-up.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011013 Pneumonectomy The excision of lung tissue including partial or total lung lobectomy. Bronchoscopic Lung Volume Reduction,Endoscopic Lung Volume Reduction,Lung Volume Reduction,Lung Volume Reduction Surgery,Partial Pneumonectomy,Partial Pneumonectomies,Pneumonectomies,Pneumonectomy, Partial,Reduction, Lung Volume,Volume Reduction, Lung
D002423 Cause of Death Factors which produce cessation of all vital bodily functions. They can be analyzed from an epidemiologic viewpoint. Causes of Death,Death Cause,Death Causes
D003324 Coronary Artery Disease Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. Arteriosclerosis, Coronary,Atherosclerosis, Coronary,Coronary Arteriosclerosis,Coronary Atherosclerosis,Left Main Coronary Artery Disease,Left Main Coronary Disease,Left Main Disease,Arterioscleroses, Coronary,Artery Disease, Coronary,Artery Diseases, Coronary,Atheroscleroses, Coronary,Coronary Arterioscleroses,Coronary Artery Diseases,Coronary Atheroscleroses,Left Main Diseases
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

Haruaki Hino, and Takahiro Karasaki, and Yukihiro Yoshida, and Takeshi Fukami, and Atsushi Sano, and Makoto Tanaka, and Yoshiaki Furuhata, and Kosuke Kashiwabara, and Junji Ichinose, and Mitsuaki Kawashima, and Jun Nakajima
September 1981, Schweizerische medizinische Wochenschrift,
Haruaki Hino, and Takahiro Karasaki, and Yukihiro Yoshida, and Takeshi Fukami, and Atsushi Sano, and Makoto Tanaka, and Yoshiaki Furuhata, and Kosuke Kashiwabara, and Junji Ichinose, and Mitsuaki Kawashima, and Jun Nakajima
June 1997, Acta medica Okayama,
Haruaki Hino, and Takahiro Karasaki, and Yukihiro Yoshida, and Takeshi Fukami, and Atsushi Sano, and Makoto Tanaka, and Yoshiaki Furuhata, and Kosuke Kashiwabara, and Junji Ichinose, and Mitsuaki Kawashima, and Jun Nakajima
January 2012, Hepato-gastroenterology,
Haruaki Hino, and Takahiro Karasaki, and Yukihiro Yoshida, and Takeshi Fukami, and Atsushi Sano, and Makoto Tanaka, and Yoshiaki Furuhata, and Kosuke Kashiwabara, and Junji Ichinose, and Mitsuaki Kawashima, and Jun Nakajima
December 1998, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics,
Haruaki Hino, and Takahiro Karasaki, and Yukihiro Yoshida, and Takeshi Fukami, and Atsushi Sano, and Makoto Tanaka, and Yoshiaki Furuhata, and Kosuke Kashiwabara, and Junji Ichinose, and Mitsuaki Kawashima, and Jun Nakajima
January 2002, Anticancer research,
Haruaki Hino, and Takahiro Karasaki, and Yukihiro Yoshida, and Takeshi Fukami, and Atsushi Sano, and Makoto Tanaka, and Yoshiaki Furuhata, and Kosuke Kashiwabara, and Junji Ichinose, and Mitsuaki Kawashima, and Jun Nakajima
July 2009, Lung cancer (Amsterdam, Netherlands),
Haruaki Hino, and Takahiro Karasaki, and Yukihiro Yoshida, and Takeshi Fukami, and Atsushi Sano, and Makoto Tanaka, and Yoshiaki Furuhata, and Kosuke Kashiwabara, and Junji Ichinose, and Mitsuaki Kawashima, and Jun Nakajima
October 1969, Der Anaesthesist,
Haruaki Hino, and Takahiro Karasaki, and Yukihiro Yoshida, and Takeshi Fukami, and Atsushi Sano, and Makoto Tanaka, and Yoshiaki Furuhata, and Kosuke Kashiwabara, and Junji Ichinose, and Mitsuaki Kawashima, and Jun Nakajima
January 2008, Hepato-gastroenterology,
Haruaki Hino, and Takahiro Karasaki, and Yukihiro Yoshida, and Takeshi Fukami, and Atsushi Sano, and Makoto Tanaka, and Yoshiaki Furuhata, and Kosuke Kashiwabara, and Junji Ichinose, and Mitsuaki Kawashima, and Jun Nakajima
January 1997, Surgery today,
Haruaki Hino, and Takahiro Karasaki, and Yukihiro Yoshida, and Takeshi Fukami, and Atsushi Sano, and Makoto Tanaka, and Yoshiaki Furuhata, and Kosuke Kashiwabara, and Junji Ichinose, and Mitsuaki Kawashima, and Jun Nakajima
January 2024, Journal of Cancer,
Copied contents to your clipboard!